Copyright
©The Author(s) 2019.
World J Gastroenterol. Aug 7, 2019; 25(29): 3897-3919
Published online Aug 7, 2019. doi: 10.3748/wjg.v25.i29.3897
Published online Aug 7, 2019. doi: 10.3748/wjg.v25.i29.3897
Table 7 Recommended treatment regimens for hepatitis C virus GT5 or GT6 infections
| Recommendation category | Treatment option(s) | Treatment regimen |
| Preferred | LDV + SOF ± RBV | LDV + SOF for 12 wk [Addition of RBV may be considered based on the physician’s discretion in treating difficult-to-treat patients (treatment-experienced patients, patients with cirrhosis)]. |
| In case of previous SOF treatment failure: LDV + SOF + RBV for 12 wk | ||
| Alternative | SOF + DCV ± RBV | SOF + DCV for 12 wk (Addition of RBV may be considered if cirrhosis has not been conclusively ruled out.) |
| Cirrhosis of any class: SOF + DCV + RBV for 12 wk | ||
| If RBV is ineligible, SOF + DCV for 24 wk | ||
| Not recommended | Due to the advent of newer DAAs, pegylated interferon, boceprevir, and telaprevir-based regimens are not recommended. | |
- Citation: Colombo MG, Musabaev EI, Ismailov UY, Zaytsev IA, Nersesov AV, Anastasiy IA, Karpov IA, Golubovska OA, Kaliaskarova KS, AC R, Hadigal S. Consensus on management of hepatitis C virus infection in resource-limited Ukraine and Commonwealth of Independent States regions. World J Gastroenterol 2019; 25(29): 3897-3919
- URL: https://www.wjgnet.com/1007-9327/full/v25/i29/3897.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i29.3897